@FierceBiotech: Regeneron's arthritis drug aces Phase III with the FDA in sight. News | Follow @FierceBiotech
@JohnCFierce: What's your list of top 5 public biotechs? (Potential, management, smart execution) I'd put $BLUE in that group. Any other suggestions? | Follow @JohnCFierce
> Celgene ($CELG) has reached out to Cypher Genomics to collaborate on determining the ideal patients for clinical trials in oncology. News
> Aura Biosciences picked up the FDA's orphan drug designation for its in-development treatment for uveal melanoma. More
Medical Device News
@FierceMedDev: ICYMI yesterday: MD Anderson Cancer Center partners to start breast cancer pilot project using Apple Watch. Report | Follow @FierceMedDev
@VarunSaxena2: St. Jude says alternative imaging system is optimal during stenting procedures. Story | Follow @VarunSaxena2
@EmilyWFierce: San Francisco startup reels in $30M for disease outbreak prediction tech. More | Follow @EmilyWFierce
> Philips collaborates with Dutch hospital to develop diabetic foot disease Dx. More
> Issue that led to halt of St. Jude TAVR trial no cause for concern, EuroPCR experts say. News
Pharma News
@FiercePharma: NIH steps in with $9M Vanderbilt grant after rough season for flu vaccines. More | Follow @FiercePharma
@EricPFierce: ICYMI: #FDA blesses Baxter #saline plant in Spain for shipments to U.S. of 0.9% sodium chloride. Article | Follow @EricPFierce
@CarlyHFierce: Novo, Baxter spar over hemophilia patent amid ITC probe. Story | Follow @CarlyHFierce
> Report: Cadila next in line for injectables bulk-up as it nears deal for Claris. More
> Aspen unloads $301M worth of meds to fuel expansion abroad. News
Vaccines News
> Canadian biotech Medicago building $200M vaccine plant. Item
> Genocea's genital herpes vaccine succeeds in Ph II. More
> Takeda, Daiichi Sankyo ink flu vaccine distribution pacts with Japan's Kaketsuken. Story
> Zydus Cadila preps for big splash into India's vaccines market. Article
> U.K.'s PsiOxus scores $39M for colorectal cancer vaccine combo trial. Report
CRO News
> Quintiles' founders bank $770M in secondary offering. Item
> InVentiv invests in compliance as regulations shift for real-world studies. Story
> Quotient Clinical soars in its first year after a PE buyout. Report
> WuXi posts another big quarter as it faces a big decision. Article
Pharma Manufacturing News
> Hospira recalls solution marked as heparin. Item
> Zydus Cadila said to be buying Claris' sterile injectables biz as landscape morphs. Story
> Apotex recalling generic Zyprexa because the antipsychotic may be too weak. News
> Fund grows to $200M for victims of meningitis outbreak tied to compounder. Article
> Medicago building $200M plant to manufacture vaccines from plants. Report
Pharma Asia News
> Sinocare said to bid $1B for Bayer diabetes devices, piping Panasonic. More
> China academy plans clinical trials on artemisinin derivative aimed at lupus. News
> Japan eyes higher target for generics despite missing earlier aims. Article
> Gilead's Sovaldi faces renewed advocacy CL pressure, this time for China and Russia. Story
> Glenmark gets India nod on shares sales to foreign investors, Temasek in. Report